Join the Abacavir group to help and get support from people like you.
Abacavir News
Abacavir Use Linked to Increased Incidence of MACE
THURSDAY, Aug. 8, 2024 – For patients with HIV in the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) trial, use of abacavir was associated with an increased incidence of major adverse...
FDA Approves Triumeq for the Treatment of HIV-1 Infection
August 22, 2014 – ViiV Healthcare announced today that the US Food and Drug Administration (FDA) has approved Triumeq (abacavir 600mg, dolutegravir 50mg and lamivudine 300mg) tablets for the...